Results 171 to 180 of about 43,736 (227)

Towards the Prevention of Freezing of Gait in Parkinson's Disease

European Journal of Neuroscience, Volume 64, Issue 4, August 2026.
Freezing of gait (FOG) is a disabling complication of Parkinson's disease (PD) that remains difficult to treat. Targeting modifiable risk factors and implementing pleiotropic (lifestyle) interventions before FOG onset may potentially delay or prevent its development.
Anouk Tosserams, Jorik Nonnekes, Bastiaan R. Bloem, Elbrich M. Postma   +3 more
wiley   +1 more source

Erratum: A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders: A Consensus Statement. [PDF]

Neurol Clin Pract
europepmc   +1 more source

Gait Impairment and Alzheimer's Disease Pathology: A Narrative Review on Mechanistic Links

Geriatrics &Gerontology International, Volume 26, Issue 8, August 2026.
Gait impairment and AD‐related pathology may be linked through shared risks, preclinical AD changes, feedback effects of persistent gait dysfunction, and life‐course susceptibility, underscoring the importance of maintaining brain–body health across the lifespan. ABSTRACT In older adults, gait has emerged as an important indicator of overall health and
Ryota Sakurai, Manuel Montero‐Odasso
wiley   +1 more source

Sensor-based gait analysis in atypical parkinsonian disorders. [PDF]

Brain Behav, 2018
Raccagni C, Gaßner H, Eschlboeck S, Boesch S, Krismer F, Seppi K, Poewe W, Eskofier BM, Winkler J, Wenning G, Klucken J.   +10 more
europepmc   +1 more source

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders. [PDF]

Sci Rep, 2018
Hall S, Janelidze S, Surova Y, Widner H, Zetterberg H, Hansson O.   +5 more
europepmc   +1 more source

Levodopa Efficacy and GLP‐1 Receptor Agonists

Movement Disorders Clinical Practice, Volume 13, Issue 8, Page 2013-2014, August 2026.
Catherine Martinez, Christine Girges, Thomas Foltynie, Anne‐Marie Wills   +3 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Atypical Parkinsonian Disorders

Movement Disorders, 2005
In many neurological diseases the topography of the lesion, whatever its nature, determines the clinical signs, whereas the nature of the lesion (vascular, inflammatory, degenerative, etc.) whatever its topography, determines the time course. According to J. P. Martin (1), this general principle cannot be simply applied to diseases of the basal ganglia
Gregor K. Wenning, Werner Poewe
  +4 more sources

Neuroimaging in Parkinsonian Disorders

Neurology India, 2018
Neuroimaging (NI) in Parkinson's disease (PD) includes functional techniques like positron emission tomography (PET) and single photon emission computed tomography (SPECT), and morphological imaging using magnetic resonance imaging (MRI) and transcranial sonography to probe different aspects of the neurobiology of PD.
Madhavi, Tripathi, Atin, Kumar, Chandrasekhar, Bal   +2 more
openaire   +2 more sources

Neuromelanin in parkinsonian disorders: an update

International Journal of Neuroscience, 2017
Neuromelanin (NM) is a dark pigment that accumulates linearly with aging in substantia nigra (SN) and locus coeruleus (LC). The dual protective and toxic role of NM has been hypothesized according to its intraneuronal or extraneuronal deposition. The melanized dopaminergic neurons in SN and LC seem to have special vulnerability to neurodegeneration in ...
Martin-bastida, Antonio, Pietracupa, Sara, Piccini, Paola   +2 more
openaire   +2 more sources